Subscribe: Lymphoma / Leukemia / Myeloma News From Medical News Today
http://www.medicalnewstoday.com/rss/lymphoma-leukemia.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
acute myeloid  acute  blood cancer  blood  cancer  cells  drug  leukemia  myeloid leukemia  myeloid  new  patients  treatment 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Lymphoma / Leukemia / Myeloma News From Medical News Today

Lymphoma / Leukemia / Myeloma News From Medical News Today



Leukemia is a cancer of the blood cells, usually affecting the white blood cells, which causes these cells to not work properly. There are four main types of leukemia. Lymphoma is a type of cancer that originates in the lymphatic system. There are two mai



Copyright: Copyright 2017 Medical News Today
 



Leukemia: Cancer cells killed off with diabetes drug

Mon, 16 Oct 2017 09:00:00 PDT

Researchers find that boosting fat cells in the bone marrow using a diabetes drug not only kills off leukemic cells, but it also regenerates healthy ones.



New compound kills cancer without harming healthy cells

Mon, 09 Oct 2017 09:00:00 PDT

A proof-of-concept study shows how a new compound selectively triggers cell suicide in acute myeloid leukemia cells without harming healthy cells.



Antibiotic identified that reduces infection risk in young leukemia patients

Fri, 15 Sep 2017 06:00:00 PDT

St. Jude Children's Research Hospital researchers have identified an antibiotic that significantly reduced the odds of infections in children starting treatment for acute lymphoblastic leukemia (ALL)...



MDS symptoms: What are the signs of pre-leukemia?

Fri, 15 Sep 2017 05:00:00 PDT

MDS, or myelodysplastic syndrome, refers to a group of blood cancers. In this article, learn about the symptoms and complications of this disease.



Acute myeloid leukemia: Heart drugs may boost chemotherapy

Thu, 31 Aug 2017 09:00:00 PDT

Researchers find that drugs normally used to treat heart and blood vessel disease could also help to improve chemotherapy outcomes for patients with AML.



FDA approval brings first gene therapy to the United States

Thu, 31 Aug 2017 06:00:00 PDT

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other...



Skin cancer and rashes: Cancerous and precancerous lesions

Tue, 22 Aug 2017 00:00:00 PDT

A rash can be a sign of skin cancer. Find out the differences between cancerous and non-cancerous rashes, and the types of cancer that cause them.



Vitamin C may stop leukemia from progressing

Thu, 17 Aug 2017 09:00:00 PDT

New research finds that high-dose vitamin C can genetically 'reprogram' leukemic cells to mature and die normally, instead of replicating to cause cancer.



Leukemia: Mushroom protein could be used in future treatments

Sun, 13 Aug 2017 00:00:00 PDT

A protein found in the edible mushroom commonly known as "shaggy ink cap" has the potential to kill leukemia T cells, a new study suggests.



Drug hope for acute myeloid leukaemia

Fri, 11 Aug 2017 00:00:00 PDT

A new drug that strips cancer cells of their "immortality" could help to treat patients suffering from one of the most aggressive forms of leukaemia.



FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia

Fri, 04 Aug 2017 06:00:00 PDT

The U.S. Food and Drug Administration has approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with...



Leukemia breakthrough: Blood molecule key to treating AML

Fri, 04 Aug 2017 00:00:00 PDT

Heme, a chemical structure found in hemoglobin, is key to treating acute myeloid leukemia, an aggressive form of blood cancer, researchers have discovered.



FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia

Wed, 02 Aug 2017 06:00:00 PDT

The U.S. Food and Drug Administration has approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic...



Cell mechanism discovery could lead to 'fundamental' change in leukemia treatment

Mon, 31 Jul 2017 00:00:00 PDT

Researchers have identified a new cell mechanism that could lead to a fundamental change in the diagnosis and treatment of leukaemia.



Scientists make breakthrough in reversing treatment resistance in blood cancer patients

Wed, 19 Jul 2017 00:00:00 PDT

Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.



CAR T-cell therapy for leukemia leads to remissions in clinical trial

Wed, 19 Jul 2017 00:00:00 PDT

Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common adult leukemia had their tumors shrink or disappear following an experimental chimeric...



Human antibody bolsters cancer drug performance

Sat, 01 Jul 2017 00:00:00 PDT

Some patients do not respond to the cancer drug rituximab, but breaking research finds that the addition of a human antibody reduces this resistance.



The gene behind follicular lymphoma

Thu, 29 Jun 2017 06:00:00 PDT

EPFL scientists have discovered an important gene whose loss lies behind follicular lymphoma, an incurable cancer.



New antibody uses one-two punch to potentially treat blood cancers

Tue, 27 Jun 2017 00:00:00 PDT

Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells directly and/or 2) driving them from the nurturing bone marrow environment into the peripheral...



Protein network signals found to drive myeloid leukemias

Fri, 16 Jun 2017 00:00:00 PDT

Researchers have uncovered how mutations in a protein network drive several high-risk leukemias, offering new prospects for novel therapies.



Precision therapy enasidenib effective in treating deadly form of leukemia

Mon, 12 Jun 2017 00:00:00 PDT

Some patients with relapsed or treatment-resistant acute myeloid leukemia, a form of blood cancer for which there are few treatments, may achieve remission with an experimental targeted therapy...



Cannabinoids and chemotherapy in combination kill cancer cells

Wed, 07 Jun 2017 00:00:00 PDT

Certain chemicals in cannabis have a potent leukemia-fighting prowess. New research shows that the key to killing cancer is the combination and order.



Study leads to breakthrough in better understanding acute myeloid leukemia

Wed, 24 May 2017 09:00:00 PDT

A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukaemia.



New test more effective at predicting survival in blood cancer patients

Thu, 11 May 2017 00:00:00 PDT

Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.



Hodgkin lymphoma survivors have more severe coronary artery disease post chest irradiation

Tue, 09 May 2017 00:00:00 PDT

Findings support argument for coronary artery disease screening after irradiationHodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to...